Lidocaine and Zolmitriptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lidocaine and Zolmitriptan. Common interactions include discomfort among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people who take Lidocaine and Zolmitriptan have. It is created by eHealthMe based on reports of 11 people who take Lidocaine and Zolmitriptan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

11 people who take Lidocaine and Zolmitriptan together, and have interactions are studied.


What is Lidocaine?

Lidocaine has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 15,232 Lidocaine users for its effectiveness, alternative drugs and more.

What is Zolmitriptan?

Zolmitriptan has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 1,919 Zolmitriptan users for its effectiveness, alternative drugs and more.

Number of Lidocaine and Zolmitriptan reports submitted per year:

Lidocaine and Zolmitriptan drug interactions.

Common Lidocaine and Zolmitriptan drug interactions by gender *:

female:

  1. Discomfort
  2. Disturbance in attention
  3. Dizziness
  4. Drug intolerance
  5. Fatigue
  6. Headache
  7. Hypotension
  8. Mastoiditis
  9. Myalgia
  10. Nausea

male:

  1. Anhedonia
  2. Anxiety
  3. Hip arthroplasty
  4. Multiple fractures
  5. Osteopenia
  6. Osteoporosis
  7. Renal failure
  8. Rotator cuff repair
  9. Spinal cord injury
  10. Upper limb fracture

Common Lidocaine and Zolmitriptan drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hypotension
  2. Mastoiditis
  3. Myalgia
  4. Nausea
  5. Otitis media
  6. Paranasal cyst
  7. Stress
  8. Therapeutic response decreased
  9. Tremor
  10. Drug ineffective

50-59:

  1. Eye discharge
  2. Eye disorder
  3. Eye injury

60+:

  1. Bradycardia

Common conditions people have *:

  1. Immunodeficiency Common Variable: 2 people, 18.18%
  2. Sunct Syndrome (short lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing): 1 person, 9.09%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
  4. Hiv Infection: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lidocaine and Zolmitriptan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Lidocaine and Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lidocaine interactions:

Browse all interactions between Lidocaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zolmitriptan interactions:

Browse all interactions between Zolmitriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine and zolmitriptan (the active ingredients of Lidocaine and Zolmitriptan, respectively), and Lidocaine and Zolmitriptan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lidocaine and Zolmitriptan.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: